Metabolic alterations in HIV-associated lipodystrophy syndrome (Q45099760)

9 December 2017

1 reference

title

Metabolic alterations in HIV-associated lipodystrophy syndrome (English)

1 reference

HIV-associated lipodystrophy

9 December 2017

main subject

1 reference

Angélica M M Valente

1

1 reference

9 December 2017

André F Reis

2

1 reference

9 December 2017

Daisy M Machado

3

1 reference

9 December 2017

Regina C M Succi

4

1 reference

9 December 2017

Antonio R Chacra

5

1 reference

9 December 2017

language of work or name

Portuguese

0 references

publication date

1 December 2005

1 reference

Arquivos Brasileiros de Endocrinologia e Metabologia

9 December 2017

published in

1 reference

9 December 2017

volume

49

1 reference

9 December 2017

issue

6

1 reference

9 December 2017

page(s)

871-881

1 reference

AIDS — The First 20 Years

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Adverse effects of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Lipodystrophy, insulin resistance, diabetes mellitus, dyslipidemia, and cardiovascular disease in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Coronary artery disease and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

"Buffalo hump" in men with HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

HIV protease inhibitor-related lipodystrophy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of 'systemic steatosis'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Hypertriglyceridemia in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Incidence of morphological and lipid abnormalities: gender and treatment differentials after initiation of first antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Lipodystrophy in patients naive to HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Metabolic effects of indinavir in healthy HIV-seronegative men

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Disorders of glucose metabolism in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Increased PAI-1 and tPA antigen levels are reduced with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Sustained benefits of metformin therapy on markers of cardiovascular risk in human immunodeficiency virus-infected patients with fat redistribution and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Acquired and inherited lipodystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine Cohort, France, 1999. Groupe d'Epidémiologie Clinique du Syndrome d'Immunodéficience Acquise en Aquitaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Reduction of abdominal obesity in lipodystrophy associated with human immunodeficiency virus infection by means of diet and exercise: case report and proof of principle

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Regression of lipodystrophy in HIV-infected patients under therapy with the new protease inhibitor atazanavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Epidemiology of HIV cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Cardiac manifestations of HIV/AIDS: a review of disease spectrum and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Cardiac manifestations of acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Myocardial infarction in HIV-infected men receiving protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Coronary artery lesions and human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Tumor necrosis factor alpha: a key component of the obesity-diabetes link

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Tumor necrosis factor alpha inhibits signaling from the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

The role of leptin in human obesity and disease: a review of current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Serum adiponectin and leptin levels in patients with lipodystrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Overexpression of the obese (ob) gene in adipose tissue of human obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Leptin-replacement therapy for lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Visceral abdominal-fat accumulation associated with use of indinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Severe premature coronary artery disease with protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

HIV-associated coronary arteritis in a patient with fatal myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Acceleration of confirmed coronary artery disease among HIV-infected patients on potent antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Are we mortgaging the medical profession?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Antiretroviral nucleoside and nucleotide analogues and mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302005000600004

10.1590/S0004-27302005000600004

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference